International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
26(1), С. 241 - 241
Опубликована: Дек. 30, 2024
Alzheimer’s
disease
(AD)
poses
a
significant
worldwide
health
challenge,
requiring
novel
approaches
for
improved
models
and
treatment
development.
This
comprehensive
review
emphasises
the
systematic
development
improvement
of
biomimetic
brain
environment
to
address
shortcomings
existing
AD
enhance
efficiency
screening
potential
drug
treatments.
We
identify
drawbacks
in
traditional
emphasise
necessity
more
physiologically
accurate
systems
through
an
in-depth
analysis
current
literature.
aims
study
advanced
model
that
accurately
replicates
key
pathophysiological
aspects
using
cutting-edge
biomaterials
microenvironment
design.
Incorporating
biomolecular
elements
like
Tau
proteins
beta-amyloid
(Aβ)
plaques
improve
accuracy
illustrating
mechanisms.
The
expected
results
involve
creating
solid
foundation
high-throughput
with
enhanced
scalability,
translational
significance,
possibility
speeding
up
discovery.
Thus,
this
fills
gaps
modelling
shows
precise
efficient
treatments
AD.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(12), С. 6766 - 6766
Опубликована: Июнь 20, 2024
The
5xFAD
transgenic
mouse
model
widely
used
in
Alzheimer’s
disease
(AD)
research
recapitulates
many
AD-related
phenotypes
with
a
relatively
early
onset
and
aggressive
age-dependent
progression.
Besides
developing
amyloid
peptide
deposits
alongside
neuroinflammation
by
the
age
of
2
months,
as
well
exhibiting
neuronal
decline
4
months
that
intensifies
9
these
mice
manifest
broad
spectrum
behavioural
impairments.
In
this
review,
we
present
extensive
repertoire
dysfunctions
mice,
organised
into
four
categories:
motor
skills,
sensory
function,
learning
memory
abilities,
neuropsychiatric-like
symptoms.
problems,
associated
agility
reflex
movements,
balance
coordination,
skeletal
muscle
typically
arise
time
reach
age.
function
(such
taste,
smell,
hearing,
vision)
starts
to
deteriorate
when
buildups
spread
related
anatomical
structures.
cognitive
functions,
encompassing
such
visual
recognition,
associative,
spatial
working,
reference
learning,
show
signs
from
6
Concerning
symptoms,
comprising
apathy,
anxiety
depression,
willingness
for
exploratory
behaviour,
it
is
believed
motivational
changes
emerge
approximately
Unfortunately,
numerous
studies
different
laboratories
are
often
contradictory
on
conclusions
drawn
identification
age,
making
preclinical
rodent
models
not
easily
translatable
humans.
This
variability
likely
due
range
factors
animals
themselves,
housing
husbandry
conditions,
experimental
settings.
forthcoming
studies,
greater
clarity
details
conducting
testing
could
minimise
inconsistencies
ensure
reliability
reproducibility
results.
Behavioural Brain Research,
Год журнала:
2024,
Номер
465, С. 114970 - 114970
Опубликована: Март 24, 2024
Alzheimer's
disease
(AD)
patients
show
age-related
decreases
in
the
ability
to
perform
activities
of
daily
living
and
decline
these
is
related
severity
neurobiological
deterioration
underlying
disease.
The
5xFAD
mouse
model
AD
shows
impairments
sensory-
motor
cognitive
function,
but
little
known
about
changes
species-typical
behaviours
that
may
patients.
Therefore,
we
examined
used
as
indices
exploration
(rearing)
compulsivity
(grooming)
across
six
tests
anxiety-like
behaviour
or
function
female
mice
from
3-16
months
age.
Robust
rearing
were
found
all
after
9
age,
although
few
differences
observed
grooming.
A
fine-scale
analysis
grooming,
however,
revealed
a
previously
unresolved
spatially
restricted
pattern
grooming
at
13-16
We
then
home-cage,
impaired
nest
building
ages
tested.
Lastly,
relationship
between
reduced
species
typical
presentation
freezing
behaviour,
commonly
measure
memory
for
conditioned
fear.
These
results
showed
along
with
sensory-motor
have
robust
behaviours.
help
patients,
provide
useful
behavioural
phenotypes
evaluating
pre-clinical
efficacy
novel
therapeutics
AD.
Frontiers in Aging Neuroscience,
Год журнала:
2025,
Номер
17
Опубликована: Апрель 28, 2025
Alzheimer's
disease
(AD)
is
characterized
by
progressive
cognitive
decline
and
has
a
long
prodromal
phase
during
which
subclinical
deficits
neuropsychiatric
symptoms
may
begin
to
emerge.
Apathy,
defined
as
lack
of
motivation
or
volition,
increasingly
recognized
core
feature
potentially
early
marker
AD.
Despite
its
significance,
apathy-like
behavior
been
underexplored
in
transgenic
models
We
performed
longitudinal
analysis
using
the
well-established
TgF344-AD
rat
model.
compared
male
female
wildtype
rats
on
hedonic
(palatable
food
intake)
motivational
(progressive
ratio)
assays
(3-4
months),
intermediate
(6-7
later
(9-10
months)
stages
adulthood.
found
that
exhibited
persistent
feeding,
emerging
at
3-4
months
6-7
months,
respectively.
During
battery
tests
conducted
after
12-14
age,
were
impaired
spatial
working
memory
but
also
showed
wide-ranging
exploratory
behavior,
be
indicative
an
loss
investigatory
drive.
Our
findings
highlight
valuable
model
for
studying
AD
underscore
need
consider
sex
differences
research
better
understand
this
disease.
Behavioural Brain Research,
Год журнала:
2023,
Номер
456, С. 114707 - 114707
Опубликована: Окт. 9, 2023
Apathy
is
the
most
common
behavioural
and
psychological
symptom
in
Alzheimer's
disease
(AD)
other
neurodegenerative
diseases
including
frontotemporal
dementia
(FTD)
Parkinson's
(PD).
In
patients,
apathy
can
include
symptoms
of
loss
motivation,
initiative,
interest,
listlessness,
indifference,
flattening
emotions,
absence
drive
passion.
Researchers
have
later
refined
this
to
a
reduction
goal
direct
behaviours.
animals,
specific
apathy-like
behaviour
been
modelled
directed
or
nest-building
which
are
seen
as
indicative
proxies
for
motivation
daily
activities.
present
study
protocol
was
established
using
four
different
inbred
mouse
strains
(CD1,
BALB/c,
C57Bl/6J,
C3H)
before
assessing
AD
FTD
tau
transgenic
mice
Line
1
(L1)
66
(L66)
paradigm.
Female
aged
5
-
6
months
were
assessed
home
cage
over
period
7
days
with
scored
by
three
independent
experimenters
at
intervals
1-,
2-
7-days
post
nestlet
introduction.
Inbred
displayed
levels
nesting
behaviour.
BALB/c
more
proficient
than
CD1
C3H
mice,
while
all
similar
day
7.
models,
L66
presented
impaired
compared
wild-type
on
2
(not
7),
whereas
L1
performed
like
days.
Anhedonia
measured
sucrose
preference
test
only
observed
L66.
low
scores
phenotypes.
Differences
evident
between
models
likely
due
human
species
expressed
these
mice.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Июнь 16, 2024
Abstract
INTRODUCTION
Skeletal
muscle
regulates
central
nervous
system
(CNS)
function
and
health,
activating
the
muscle-to-brain
axis
through
secretion
of
skeletal
originating
factors
(‘myokines’)
with
neuroprotective
properties.
However,
precise
mechanisms
underlying
these
benefits
in
context
Alzheimer’s
disease
(AD)
remain
poorly
understood.
METHODS
To
investigate
signaling
response
to
amyloid
β
(Aβ)-
induced
toxicity,
we
generated
5xFAD
transgenic
female
mice
enhanced
(5xFAD;cTFEB;HSACre)
at
prodromal
(4-months
old)
late
(8-months
symptomatic
stages.
RESULTS
TFEB
overexpression
reduced
Aβ
plaque
accumulation
cortex
hippocampus
both
ages
rescued
behavioral
neurocognitive
deficits
8-
months-old
mice.
These
changes
were
associated
transcriptional
protein
remodeling
neurotrophic
synaptic
integrity,
partially
due
CNS-targeting
myokine
prosaposin
(PSAP).
DISCUSSION
Our
findings
implicate
as
a
novel
pathway
against
pathogenesis
AD.
Disease Models & Mechanisms,
Год журнала:
2023,
Номер
16(10)
Опубликована: Сен. 29, 2023
ABSTRACT
Variants
in
the
ubiquitously
expressed
DNA/RNA-binding
protein
FUS
cause
aggressive
juvenile
forms
of
amyotrophic
lateral
sclerosis
(ALS).
Most
mutation
studies
have
focused
on
motor
neuron
degeneration;
little
is
known
about
wider
systemic
or
developmental
effects.
We
studied
pleiotropic
phenotypes
a
physiological
knock-in
mouse
model
carrying
pathogenic
FUSDelta14
homozygosity.
RNA
sequencing
multiple
organs
aimed
to
identify
pathways
altered
by
mutant
transcriptome,
including
metabolic
tissues,
given
link
between
ALS-frontotemporal
dementia
and
metabolism.
Few
genes
were
commonly
across
all
most
affected
generally
tissue
specific.
Phenotypic
assessment
mice
revealed
alterations
related
pathway
changes
identified.
Magnetic
resonance
imaging
brain
scans
histological
characterisation
that
homozygous
brains
smaller
than
heterozygous
wild-type
displayed
significant
morphological
alterations,
thinner
cortex,
reduced
neuronal
number
increased
gliosis,
which
correlated
with
early
cognitive
impairment
fatal
seizures.
These
findings
show
disease
aetiology
variants
can
include
both
neurodevelopmental
alterations.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 23, 2024
Abstract
Immunotherapy
of
Alzheimer’s
disease
(AD)
is
a
promising
approach
to
reduce
the
accumulation
amyloid-beta
(Aβ),
critical
event
in
onset
disease.
Targeting
group
II
metabotropic
glutamate
receptors,
mGlu2
and
mGlu3,
could
be
important
controlling
Aβ
production,
although
their
respective
contribution
remains
unclear
due
lack
selective
tools.
Here,
we
show
that
enhancing
receptor
activity
increases
1-42
peptide
production
whereas
activation
mGlu3
has
no
effect.
We
such
difference
likely
results
from
direct
interaction
APP
with
but
not
prevents
amyloidogenic
cleavage
peptides
production.
then
chronic
treatments
AD
model
5xFAD
mice
brain-penetrating
mGlu2-potentiating
nanobody
accelerated
amyloid
aggregation
exacerbated
memory
deficits,
had
effect
control
mice.
Our
confirm
mGluR2
exacerbates
development,
suggesting
therapeutic
benefices
obtained
blockers
this
receptor.
study
also
provides
proof-of-concept
administration
nanobodies
targeting
neuroreceptors
can
envisioned
treat
brain
diseases.
Journal of Alzheimer s Disease,
Год журнала:
2024,
Номер
101(4), С. 1217 - 1226
Опубликована: Окт. 8, 2024
Background:
Apathy
is
a
state
of
decreased
interest,
lack
initiative,
reduced
goal-directed
activity
and
blunted
emotional
responses.
one
the
most
common
neuropsychiatric
symptoms
(NPS)
in
patients
with
Alzheimer’s
disease
(AD)
also
relatively
omnipresent
individuals
Down
syndrome
(DS).
Little
known
about
apathy-like
behaviors
rodent
models
AD
DS.
Objective:
This
study
aimed
to
characterize
aging
two
established
DS
mouse
models:
Ts65Dn
Dp16.
Methods:
A
battery
behavioral
tests
including
nestlet
shredding,
marble
burying,
nest
building,
burrowing
were
performed
examine
behaviors.
Individual
z-scores
for
each
test,
composite
z-score
behavior
analyzed
all
mice
from
these
tests.
Results:
Analysis
individual
test
results
revealed
significant
compared
WT
controls.
In
contrast,
Dp16
did
not
exhibit
Conclusions:
Our
first
highlights
difference
between
model
regarding
manifestations
aging.